Is a Correction Looming Ahead for Hims & Hers Health Inc. (HIMS) – News Heater
Home  »  Business   »  Is a Correction Looming Ahead for Hims & Hers...

Is a Correction Looming Ahead for Hims & Hers Health Inc. (HIMS)

Hims & Hers Health Inc. (NYSE:HIMS) went down by -6.47% from its latest closing price compared to the recent 1-year high of $15.55. The company’s stock price has collected -19.86% of loss in the last five trading sessions.

Is It Worth Investing in Hims & Hers Health Inc. (NYSE :HIMS) Right Now?

Opinions of the stock are interesting as 4 analysts out of 7 who provided ratings for Hims & Hers Health Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored

The average price from analysts is $7.46, which is $4.07 above the current price. HIMS currently public float of 154.32M and currently shorts hold a 5.22% ratio of that float. Today, the average trading volume of HIMS was 2.21M shares.

HIMS’s Market Performance

HIMS stocks went down by -19.86% for the week, with a monthly drop of -27.41% and a quarterly performance of -25.54%, while its annual performance rate touched -64.95%. The volatility ratio for the week stands at 9.46% while the volatility levels for the past 30 days are set at 7.12% for Hims & Hers Health Inc.. The simple moving average for the period of the last 20 days is -24.00% for HIMS stocks with a simple moving average of -45.69% for the last 200 days.

Analysts’ Opinion of HIMS

Many brokerage firms have already submitted their reports for HIMS stocks, with Guggenheim repeating the rating for HIMS by listing it as a “Buy.” The predicted price for HIMS in the upcoming period, according to Guggenheim is $10 based on the research report published on April 14th of the current year 2022.

Credit Suisse, on the other hand, stated in their research note that they expect to see HIMS reach a price target of $8. The rating they have provided for HIMS stocks is “Outperform” according to the report published on April 01st, 2022.

Deutsche Bank gave a rating of “Hold” to HIMS, setting the target price at $7 in the report published on March 10th of the current year.

HIMS Trading at -27.55% from the 50-Day Moving Average

After a stumble in the market that brought HIMS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -77.68% of loss for the given period.

Volatility was left at 7.12%, however, over the last 30 days, the volatility rate increased by 9.46%, as shares sank -27.25% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -33.52% lower at present.

During the last 5 trading sessions, HIMS fell by -19.86%, which changed the moving average for the period of 200-days by -57.63% in comparison to the 20-day moving average, which settled at $4.50. In addition, Hims & Hers Health Inc. saw -47.02% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at HIMS starting from O’Keefe Lynne Chou, who sale 10,044 shares at the price of $4.50 back on Mar 17. After this action, O’Keefe Lynne Chou now owns 0 shares of Hims & Hers Health Inc., valued at $45,198 using the latest closing price.

O’Keefe Lynne Chou, the Director of Hims & Hers Health Inc., sale 40,178 shares at $5.04 during a trade that took place back on Mar 02, which means that O’Keefe Lynne Chou is holding 0 shares at $202,497 based on the most recent closing price.

Stock Fundamentals for HIMS

Current profitability levels for the company are sitting at:

  • -42.31 for the present operating margin
  • +73.72 for the gross margin

The net margin for Hims & Hers Health Inc. stands at -39.60. Equity return is now at value -33.80, with -28.10 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 3.41.

Leave a Comment

Your email address will not be published.

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam